Briceno et al. demonstrated that CD73−CD8+T-cells expressed lower levels of exhaustion markers and were more effective in reducing tumor burden in melanoma bearing mice, compared to CD73+CD8+T-cells [203]. This evidence concerns the gene CD8A and melanoma.